Recombinant Human IFN-alpha/beta R2/IFNAR2 protein

Cat No.
ATGP3952

Size

QTY

List Price

10ug

USD 80


20ug

USD 130

50ug

USD 180

100ug

USD 300

250ug

USD 530

500ug

USD 900

1mg

USD 1,510

USD 0



Product Information

Product Type
Recombinant Protein
Expression System
Baculovirus
Domain
27-243aa
UniProt No.
P48551
NCBI Accession No.
NP_997468
Alternative names
Interferon alpha/beta receptor 2, IFNAR2, IFN-alpha binding protein, Interferon alpha binding protein, Type I interferon receptor 2, interferon alpha/beta receptor 2 isoform a, IFN-R-2, IFNABR, IFNARB, IFN-alpha-REC, IFN-R, IMD45

Product Specification

Molecular Weight
51.7kDa (456aa)
Concentration
0.25mg/ml (determined by Absorbance at 280nm)
Formulation
Liquid in. Phosphate-Buffered Saline (pH 7.4) containing 10% glycerol
Purity
> 90% by SDS-PAGE
Bioactivity
Measured by its binding ability in a functional ELISA with Human IFN-alpha 2 (CAT# IFN0502) in the presence of Human IFN-alpha/beta R1 (CAT# ATGP3894). The ED50 range ≤ 500 ng/ml.
Endotoxin
< 1 EU per 1ug of protein (determined by LAL method)
Tag
hIgG-His-Tag
Applications
SDS-PAGE, Bioactivity
Storage
Can be stored at +2C to +8C for 1 week. For long term storage, aliquot and store at -20C to -80C. Avoid repeated freezing and thawing cycles.

Data

SDS-PAGE

3ug by SDS-PAGE under reducing condition and visualized by coomassie blue stain

Biological Activity

Human IFN-alpha 2 (CAT# IFN0502) is coated at 10 ug/ml (100 ul/well) can bind Human IFN-alpha/beta R2 in the presence of Human IFN-alpha/beta R1 (CAT# ATGP3894). The ED50 range ≤ 500 ng/ml.

Note: For research use only. This product is not intended or approved for human, diagnostics or veterinary use.